Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Following threats from the Food and Drug Administration (FDA) that it would take “decisive” action against companies selling “illegal copycat drugs,” telehealth company Hims & Hers announced it would pull…

